PDEX
PRO-DEX Posts 17% Q4 Sales Growth as Gross Margin Jumps to 35%
The surgical device maker reported fiscal 2026 net sales of $77.5 million and full-year diluted EPS of $4.12, helped by its largest customer's next-generation handpiece.
PDEX
Market-moving news on Pro-Dex (NASDAQ: PDEX): filings, earnings, deals and other events, from REDFILED.